Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	489	453	311.66	243.78	234.31	228.63
Short-Term Investments	17.96	14.19	41.8	79.33	-	-
Cash & Short-Term Investments	506.95	467.19	353.46	323.12	234.31	228.63
Cash Growth	36.15%	32.17%	9.39%	37.90%	2.48%	834.83%
Receivables	105.97	83.03	74.14	54.74	34.84	22.18
Inventory	6.38	7.2	5.36	4.3	4.43	3.82
Prepaid Expenses	16.47	13.71	12.57	9.35	7.64	6.96
Other Current Assets	6.92	8.12	5.54	8.79	3.22	1.3
Total Current Assets	642.69	579.25	451.07	400.29	284.44	262.89
Property, Plant & Equipment	3.1	3.38	2.72	2.89	4.12	0.94
Long-Term Investments	103.25	108.87	72.17	22.57	-	-
Other Intangible Assets	107.3	113.26	137.11	160.95	143.92	162.34
Long-Term Deferred Tax Assets	194.71	190.4	144.16	85.94	-	-
Other Long-Term Assets	4.48	4.03	4.22	1.24	0.97	0.9
Total Assets	1,056	999.2	811.45	673.87	433.44	427.07
Accounts Payable	17.46	13.74	17.73	3.79	1	2.56
Accrued Expenses	120.28	139.42	123.24	71.47	49.41	31.67
Current Portion of Long-Term Debt	17.5	16.25	15	2	2	-
Current Portion of Leases	1.15	1.32	1.44	1.61	1.36	-
Other Current Liabilities	18.73	4.35	6.37	0.01	-	100.31
Total Current Liabilities	175.12	175.08	163.78	78.88	53.78	134.54
Long-Term Debt	158.18	163.02	178.57	189.65	189.98	194.25
Long-Term Leases	0.63	0.82	1.08	0.98	2.4	-
Other Long-Term Liabilities	1.08	1.13	1.03	1.53	0.78	1.11
Total Liabilities	335.01	340.05	344.46	271.03	246.94	329.89
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	672.5	656.87	610.27	675.12	640.1	585.37
Retained Earnings	47.78	2.22	-143.28	-272.13	-453.6	-488.2
Comprehensive Income & Other	0.25	0.07	0	-0.15	-	-
Total Common Equity	720.53	659.16	466.99	402.84	186.51	97.18
Shareholders' Equity	720.53	659.16	466.99	402.84	186.51	97.18
Total Liabilities & Equity	1,056	999.2	811.45	673.87	433.44	427.07
Total Debt	177.46	181.41	196.09	194.24	195.74	194.25
Net Cash (Debt)	329.49	285.78	157.38	128.88	38.57	34.38
Net Cash Growth	83.78%	81.59%	22.11%	234.19%	12.17%	-
Net Cash Per Share	5.67	4.94	2.61	2.11	0.65	1.33
Filing Date Shares Outstanding	57.42	57.35	56.77	59.62	58.87	56.89
Total Common Shares Outstanding	57.39	57.14	56.77	59.62	58.83	56.89
Working Capital	467.57	404.17	287.29	321.4	230.66	128.35
Book Value Per Share	12.55	11.53	8.23	6.76	3.17	1.71
Tangible Book Value	613.22	545.89	329.88	241.89	42.59	-65.16
Tangible Book Value Per Share	10.68	9.55	5.81	4.06	0.72	-1.15

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q